达安基因
(002030)
| 流通市值：81.68亿 | | | 总市值：81.68亿 |
| 流通股本：14.03亿 | | | 总股本：14.03亿 |
| 报告期 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 872,086,093.74 | 773,441,188.75 | 756,264,878.74 | 798,472,734.66 |
| 结算备付金 | 0 | 0 | 0 | 0 |
| 拆出资金 | 0 | 0 | 0 | 0 |
| 衍生金融资产 | 0 | 0 | 0 | 0 |
| 应收票据及应收账款 | 1,255,348,594 | 1,462,631,721.56 | 1,688,611,790.72 | 1,876,414,563.49 |
| 其中：应收票据 | 1,003,826.48 | 572,129.98 | 797,528 | 3,999,381.2 |
| 应收账款 | 1,254,344,767.52 | 1,462,059,591.58 | 1,687,814,262.72 | 1,872,415,182.29 |
| 应收款项融资 | 6,281,073.96 | 36,482,133.42 | 77,457,596.44 | 82,842,186.92 |
| 预付款项 | 49,826,004.71 | 56,205,255.16 | 45,825,065.59 | 48,991,435.9 |
| 应收保费 | 0 | 0 | 0 | 0 |
| 应收分保账款 | 0 | 0 | 0 | 0 |
| 应收分保合同准备金 | 0 | 0 | 0 | 0 |
| 其他应收款合计 | 33,620,637.48 | 51,759,180.59 | 43,242,719.34 | 46,825,797.65 |
| 其中:应收利息 | 0 | 0 | 0 | 0 |
| 应收股利 | 0 | 0 | 3,824,783.63 | 0 |
| 买入返售金融资产 | 0 | 0 | 0 | 0 |
| 存货 | 198,214,544.62 | 238,323,924.36 | 258,063,498.15 | 251,295,222.52 |
| 合同资产 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动资产 | 72,745,563.12 | 95,093,165.35 | 121,085,163.2 | 106,359,326.39 |
| 其他流动资产 | 1,024,092,823.13 | 1,951,644,802.12 | 1,893,170,991.4 | 2,045,047,706.96 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,781,514,679.73 | 5,038,924,096.39 | 5,245,998,829.81 | 5,496,322,827.79 |
| 非流动资产: | | | | |
| 发放委托贷款及垫款 | 18,556,065 | 15,025,824 | 15,025,824 | 16,186,500 |
| 债权投资 | 0 | 0 | 0 | 0 |
| 其他债权投资 | 0 | 0 | 0 | 0 |
| 长期应收款 | 87,466,186.96 | 58,347,794.5 | 36,962,939.8 | 29,155,895.56 |
| 长期股权投资 | 516,340,594.35 | 664,124,061.76 | 778,509,481.04 | 815,800,081.58 |
| 其他权益工具投资 | 0 | 0 | 0 | 0 |
| 其他非流动金融资产 | 910,557,258.26 | 961,213,610.96 | 773,583,825.66 | 715,039,047.37 |
| 投资性房地产 | 26,263,377.54 | 26,435,359.25 | 27,185,695.08 | 26,910,164.27 |
| 固定资产 | 995,992,531.91 | 1,007,640,678.54 | 1,056,966,334.16 | 1,101,889,946.34 |
| 在建工程 | 776,103,792.61 | 801,410,918.4 | 790,317,559.97 | 797,182,047.5 |
| 生产性生物资产 | 0 | 0 | 0 | 0 |
| 油气资产 | 0 | 0 | 0 | 0 |
| 使用权资产 | 17,483,002.26 | 11,841,348.58 | 15,205,752.36 | 13,084,074.16 |
| 无形资产 | 572,723,482.91 | 376,945,528.57 | 349,895,002.89 | 337,492,783.97 |
| 开发支出 | 346,892,946.53 | 543,393,207.51 | 557,563,691.06 | 568,743,228.38 |
| 商誉 | 0 | 0 | 0 | 0 |
| 长期待摊费用 | 50,683,173.23 | 50,469,762.57 | 52,719,711.64 | 55,079,227.29 |
| 递延所得税资产 | 358,394,646.38 | 288,847,052.25 | 281,749,773.47 | 265,186,196.05 |
| 其他非流动资产 | 1,117,943,953.8 | 139,308,596.38 | 144,612,666.3 | 136,384,559.31 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 5,795,401,011.74 | 4,945,003,743.27 | 4,880,298,257.43 | 4,878,133,751.78 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 9,576,915,691.47 | 9,983,927,839.66 | 10,126,297,087.24 | 10,374,456,579.57 |
| 流动负债: | | | | |
| 短期借款 | 143,534,033.02 | 146,260,103.59 | 111,695,323.53 | 326,571,066.73 |
| 向中央银行借款 | 0 | 0 | 0 | 0 |
| 吸收存款及同业存放 | 0 | 0 | 0 | 0 |
| 拆入资金 | 0 | 0 | 0 | 0 |
| 交易性金融负债 | 0 | 0 | 0 | 0 |
| 衍生金融负债 | 0 | 0 | 0 | 0 |
| 应付票据及应付账款 | 357,870,979.66 | 384,692,585.35 | 405,601,812.97 | 391,784,195.26 |
| 其中：应付票据 | 0 | 0 | 0 | 0 |
| 应付账款 | 357,870,979.66 | 384,692,585.35 | 405,601,812.97 | 391,784,195.26 |
| 预收款项 | 0 | 0 | 0 | 0 |
| 合同负债 | 66,225,724.48 | 36,508,293.64 | 35,186,457.1 | 40,435,199.8 |
| 卖出回购金融资产款 | 0 | 0 | 0 | 0 |
| 应付手续费及佣金 | 0 | 0 | 0 | 0 |
| 应付职工薪酬 | 525,668,125.45 | 489,971,940.6 | 510,696,391.54 | 533,703,465.64 |
| 应交税费 | 35,505,042.73 | 30,969,387.46 | 33,698,871.25 | 36,285,737.43 |
| 其他应付款合计 | 107,031,384.32 | 87,660,528.46 | 107,439,929.1 | 89,150,937.05 |
| 其中:应付利息 | 0 | 0 | 0 | 0 |
| 应付股利 | 0 | 0 | 0 | 0 |
| 应付分保账款 | 0 | 0 | 0 | 0 |
| 保险合同准备金 | 0 | 0 | 0 | 0 |
| 代理买卖证券款 | 0 | 0 | 0 | 0 |
| 代理承销证券款 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动负债 | 10,703,779.35 | 10,105,325.03 | 14,803,569.55 | 7,874,318.36 |
| 其他流动负债 | 4,487,095.12 | 1,335,427.93 | 1,393,455.45 | 1,873,052.7 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,293,746,807.26 | 1,230,057,635.19 | 1,263,069,853.62 | 1,470,232,016.1 |
| 非流动负债: | | | | |
| 长期借款 | 0 | 0 | 0 | 0 |
| 应付债券 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 租赁负债 | 13,455,472.8 | 15,347,918.32 | 18,595,821.41 | 23,803,754.46 |
| 长期应付款 | 5,500,713 | 5,620,000 | 4,625,000 | 5,445,000 |
| 长期应付职工薪酬 | 0 | 0 | 0 | 0 |
| 预计负债 | 1,427,494.51 | 97,970.75 | 113,918.22 | 113,918.22 |
| 递延收益 | 58,529,052.49 | 64,328,757.28 | 71,223,727.4 | 29,304,522.31 |
| 递延所得税负债 | 61,235,066.02 | 66,699,576.17 | 48,873,154.19 | 49,410,654.37 |
| 其他非流动负债 | 0 | 0 | 0 | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 140,147,798.82 | 152,094,222.52 | 143,431,621.22 | 108,077,849.36 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,433,894,606.08 | 1,382,151,857.71 | 1,406,501,474.84 | 1,578,309,865.46 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,403,446,032 | 1,403,446,032 | 1,403,446,032 | 1,403,446,032 |
| 其他权益工具 | 0 | 0 | 0 | 0 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 资本公积 | 600,972,357.38 | 618,680,834.83 | 632,485,432.99 | 651,544,521.92 |
| 减:库存股 | 0 | 0 | 0 | 0 |
| 其他综合收益 | -7,412,048.13 | -3,757,445.91 | -3,475,098.85 | -3,696,565.71 |
| 专项储备 | 0 | 0 | 0 | 0 |
| 盈余公积 | 1,271,543,871.4 | 1,271,543,871.4 | 1,271,543,871.4 | 1,271,543,871.4 |
| 一般风险准备 | 0 | 0 | 0 | 0 |
| 未分配利润 | 4,611,398,980.79 | 5,033,849,142.7 | 5,137,349,811.49 | 5,194,329,897.21 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,879,949,193.44 | 8,323,762,435.02 | 8,441,350,049.03 | 8,517,167,756.82 |
| 少数股东权益 | 263,071,891.95 | 278,013,546.93 | 278,445,563.37 | 278,978,957.29 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 8,143,021,085.39 | 8,601,775,981.95 | 8,719,795,612.4 | 8,796,146,714.11 |
| 负债和股东权益合计 | 9,576,915,691.47 | 9,983,927,839.66 | 10,126,297,087.24 | 10,374,456,579.57 |
| 公告日期 | 2025-03-29 | 2024-10-31 | 2024-08-31 | 2024-04-30 |
| 审计意见(境内) | 标准无保留意见 | | | |